🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregional...
Status
Completed
Location
Xiaozhong Chen
Start Date
2017-03-13
Trial ID
NCT03025958
Treatments Being Tested
Combining nimotuzumab to gefitinib may not only potentiate cellular cytotox...
Status
Completed
Location
Severance hospital, Yonsei Cancer Center
Start Date
2011-12
Trial ID
NCT01498562
Treatments Being Tested
This is an multicenter, randomized，double-blind, controlled clinical study....
Status
Completed
Location
Cancer Institute and Hospital , Chinese Academy of Medical Sciences
Start Date
2017-07-06
Trial ID
NCT06781073
Treatments Being Tested
The purpose of this study is to define the response and toxicities with the...
Status
Completed
Location
National Cancer Center Singapore
Start Date
2008-04-28
Trial ID
NCT00702481
Treatments Being Tested
The aim of the study is to evaluate the role of nimotuzumab in the neo-adju...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2009-05
Trial ID
NCT00910117
Treatments Being Tested
Esophageal cancer is one of common malignant tumors in China and esophageal...
Status
Withdrawn
Location
Beijing Cancer Hospital & Peking University Cancer Hospital
Start Date
2014-11
Trial ID
NCT02272699
Treatments Being Tested
There have been reports suggesting that anti-epidermal growth factor antibo...
Status
Withdrawn
Location
The first affiliated hospital, Zhejiang University
Start Date
2014-02
Trial ID
NCT02034968
Treatments Being Tested
This is a randomized, Phase II study designed to investigate Nimotuzumab pl...
Status
Terminated
Location
Florida Cancer Institute - New Hope
Start Date
2009-04
Trial ID
NCT00872482
Treatments Being Tested
The objective of the present study is to estimate the overall survival of p...
Status
Completed
Location
Centre Pierre et Marie Curie (CPMC)
Start Date
2015-11
Trial ID
NCT03413579
Treatments Being Tested
This phase I/II trial studies the best dose and side effects of nimotuzumab...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-06-29
Trial ID
NCT02947386
Treatments Being Tested